Biodesix is a molecular diagnostics company that develops and commercializes blood-based diagnostic tests for oncology indications. The company's tests are designed to provide physicians with clinically actionable information to improve patient outcomes and reduce the overall cost of care. Biodesix's flagship product, the GeneStrat test, is a non-invasive liquid biopsy test that helps physicians identify the optimal treatment for patients with advanced non-small cell lung cancer. The company was founded in 2005 and is headquartered in Boulder, Colorado.